Biotech & Health

Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion, has already taken three businesses he’s founded public.  Today he’s the founder of Tempus, a genomic testing and data analysis company preparing to IPO. But […]

Billionaire Groupon founder Eric Lefkofsky is back with another IPO: AI health tech Tempus Read More »

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M

Putting AI to work in the healthcare industry is a tricky business; it’s even more so in oncology, where the stakes are especially high. Biotech startup Valar Labs is aiming high but starting small with a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients. It has raised $22 million to

Valar Labs debuts AI-powered cancer care prediction tool and secures $22M Read More »

Mental health insurance platform ifeel raises a $20 million Series B

Mental health issues like stress, depression and anxiety can lead to work-related illnesses, absences and long-term sick leave. But many companies think offering a gym membership is enough. Ifeel — a European startup that decided mental health should be tackled differently and which raised $6.6 million in 2021 — has now raised a $20 million

Mental health insurance platform ifeel raises a $20 million Series B Read More »

US pharma giant Cencora says Americans’ health information stolen in data breach

U.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and highly sensitive medical information was stolen during a cyberattack and data breach earlier this year.  In letters to affected individuals sent out this week, Cencora said that the data from its systems includes patient names, their postal address and date of

US pharma giant Cencora says Americans’ health information stolen in data breach Read More »

IndieBio’s SF incubator lineup is making some wild biotech promises

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims that could pay off in a big way. Biotech has been creeping out in recent years to touch adjacent industries, as companies find how much

IndieBio’s SF incubator lineup is making some wild biotech promises Read More »

Strava taps AI to weed out leaderboard cheats, unveils ‘family’ plan, dark mode and more

Strava on Thursday announced a slew of new features and updates at its annual Camp Strava event, as the San Francisco-headquartered company doubles down on efforts to make its social fitness app stickier both for free and premium subscribers — with artificial intelligence (AI) playing a central role. One of the perennial complaints emanating from the

Strava taps AI to weed out leaderboard cheats, unveils ‘family’ plan, dark mode and more Read More »

Google expands hands-free and eyes-free interfaces on Android

As part of 2024’s Accessibility Awareness Day, Google is showing off some updates to Android that should be useful to folks with mobility or vision impairments. Project Gameface allows gamers to use their faces to move the cursor and perform common click-like actions on desktop, and now it’s coming to Android. The project lets people

Google expands hands-free and eyes-free interfaces on Android Read More »

Dietitian startup Fay has been booming from Ozempic patients and emerges from stealth with $25M from General Catalyst, Forerunner

For years, Sammy Faycurry has been hearing from his registered dietitian (RD) mom and sister about how poorly many Americans eat and their struggles with delivering nutritional counseling. Although nearly half of all adults in the country are affected by chronic conditions linked to unhealthy diets, health plans have a limited number of in-network registered

Dietitian startup Fay has been booming from Ozempic patients and emerges from stealth with $25M from General Catalyst, Forerunner Read More »

Triomics raises $15M Series A to automate cancer clinical trials matching

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly reduce the time it takes doctors to match

Triomics raises $15M Series A to automate cancer clinical trials matching Read More »